TNF Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
TNF Pharmaceuticals has a total shareholder equity of $10.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $14.5M and $4.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.74m |
| Equity | US$10.24m |
| Total liabilities | US$4.25m |
| Total assets | US$14.49m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A8D's short term assets ($2.5M) do not cover its short term liabilities ($4.0M).
Long Term Liabilities: 0A8D's short term assets ($2.5M) exceed its long term liabilities ($279.6K).
Debt to Equity History and Analysis
Debt Level: 0A8D is debt free.
Reducing Debt: 0A8D currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A8D has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 0A8D is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.